Published by Josh White on 21st March 2019
(Sharecast News) - Data analytics and implementation services company Diaceutics confirmed the admission of its entire issued ordinary share capital, which comprises 69,583,077 ordinary shares, to trading on AIM on Thursday morning.
URL: http://www.digitallook.com/dl/news/story/28792304/...